The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies
- 1 March 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (3) , 917-925
- https://doi.org/10.1046/j.1523-1755.1999.055003917.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?Clinical and Experimental Immunology, 1997
- A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extractJournal of Immunological Methods, 1996
- Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitisClinical and Experimental Immunology, 1995
- Significance of myeloperoxidase in rapidly progressive glomerulonephritisAmerican Journal of Kidney Diseases, 1995
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model.The Journal of Experimental Medicine, 1993
- Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell linesEuropean Journal of Biochemistry, 1991
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988
- New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.Journal of Clinical Investigation, 1987